Targeted therapy in lung cancer: Are we closing the gap in years of life lost?

Abstract Purpose Patients with non‐small cell lung cancer (NSCLC) that harbor driver mutations are associated with a cancer diagnosis at a younger age. While targeted therapies provide deep remissions and durable benefit in a subset of patients, it is unclear whether targeted therapies bridge the ga...

Full description

Bibliographic Details
Main Authors: David J. Benjamin, Alyson Haslam, Jenny Gill, Vinay Prasad
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.4703